HomeNUZ • ASX
add
Neurizon Therapeutics Ltd
Previous close
$0.15
Year range
$0.096 - $0.25
Market cap
73.85M AUD
Avg Volume
264.16K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 3.20K | 140.91% |
Operating expense | 4.72M | 125.08% |
Net income | -4.66M | -27.87% |
Net profit margin | -145.62K | -412.56% |
Earnings per share | — | — |
EBITDA | -4.72M | -124.13% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.18M | -61.03% |
Total assets | 4.36M | -60.82% |
Total liabilities | 1.54M | 71.55% |
Total equity | 2.82M | — |
Shares outstanding | 492.31M | — |
Price to book | 15.00 | — |
Return on assets | -270.54% | — |
Return on capital | -418.07% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -4.66M | -27.87% |
Cash from operations | -4.48M | -74.78% |
Cash from investing | 1.50M | 399.85% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -2.98M | -239.65% |
Free cash flow | -2.79M | -138.41% |
About
Founded
2000
Website
Employees
52
